The Brighterside of News on MSN
New drug combo cuts risk of death for men with prostate cancer by 40%
Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...
Dr. Wallen: When the prostate cancer is only in the prostate and hasn't spread elsewhere, the standard of care treatments are ...
Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...
8don MSN
New imaging solution could help improve survival for patients with recurring prostate cancer
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...
The second most common cancer among men is prostate cancer, affecting 1 in 8 men. Prostate cancer is treatable, in most cases, when the cancer remains localized to the prostate gland. But if the ...
Adding Xtandi to androgen deprivation therapy and radiation did not significantly improve metastasis-free survival in ...
A multi-centre study whose leads include London-based researchers has found a new imaging solution that can more effectively ...
A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.
There is no single, diagnostic test for prostate cancer and PSA tests are not routinely used to screen healthy men because ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback